Medisilk S.p.A. is an innovative startup founded in 2018 with the aim of promoting, together with the proper industrial partner/partners, the research and development on EPIFIBROIN Medical Devices (class II B – CE) for the treatment of a wide variety of skin conditions, ranging from the aesthetic to the dermatological and wound care field, including veterinary skin diseases.
The CEO of Medisilk visits the Silk Lab at the Tufts University of Boston and meets the Professor who proposed and pioneered the use of silk as a material platform for advanced technology with uses in photonics, optoelectronics, and nanotechnology applications.
MAY 2019 Second meeting with a medical and marketing team of a pharmaceutical company: discussion and proposal of an action plan for the use of Epifibroin Powder for the treatment of severe ulcers.
DECEMBER 2018 The scientific study “Epifibroin 0039 dressing and powder as a therapeutic aid for erosive and ulcerated dermatoses of the skin and mucosa: an investigative study” is published in European Journal of Dermatology, 2018, Volume 28, Numero 6
2017 The results of the use of the powder in patients suffering from gynecological diseases, ulcers, pemphigus and burns were presented at medical congresses.
Poster presentation at Association of Dermatologists Venereologists Italian Hospitals and Public Health ADOI National Congress – Rome 18/21 October 2017Download
Poster presentation at The School of Psoriasis – Naple 27/28 October 2017Download
Poster presentation at Italian Society of Professional Allergology and environmental Dermatology SIDAPA National Congress – Florence 5/7 October 2017 Download